Answer
St John's wort should be avoided during Korserdu (elacestrant dihydrochloride) treatment because it is a strong CYP3A4 inducer; an alternative with no or minimal CYP3A4-inducing potential should be considered, and if unavoidable, Korserdu dose adjustment should be applied.
Sources for this answer
- Korserdu (elacestrant) 345mg film-coated tabletsMenarini Stemline UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 3Document updated
Sources checked